rawfin.tv
City of Hope, Quest Diagnostics Partner on Blood Test for Cancer Recurrence
TechnologytechAI Generated

City of Hope, Quest Diagnostics Partner on Blood Test for Cancer Recurrence

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

City of Hope and Quest Diagnostics have initiated a multi-year research collaboration to evaluate the Haystack MRD® circulating tumor DNA blood test. The study aims to track 500 patients for earlier detection of cancer recurrence.

healthcarebiotechmedical researchcancerdiagnostics

Related Articles

Anthropic S-1 Filing Reveals $80.7 Billion First-Half Loss Ahead of IPO

Anthropic S-1 Filing Reveals $80.7 Billion First-Half Loss Ahead of IPO

tech
Apple Partners with Meta to Run 816-Billion AI Model Locally

Apple Partners with Meta to Run 816-Billion AI Model Locally

tech
Nvidia Market Share in China AI Chips Drops to 34 Percent as Huawei Gains Ground

Nvidia Market Share in China AI Chips Drops to 34 Percent as Huawei Gains Ground

tech
Nvidia Market Share in China Declines as Huawei Expands AI Chip Reach

Nvidia Market Share in China Declines as Huawei Expands AI Chip Reach

tech